These success, together with a previous report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,2 guidance the idea of targeting ACKR3 as a novel strategy to modulate the opioid process, which could open new therapeutic avenues for opioid-associated Diseases. Title your selection: Title has to https://jamesh283ypf8.blogozz.com/profile